Annals of Oncology

Editorials:

Avraham Eisbruch

Dysphagia and aspiration following chemo-irradiation of head and neck cancer: major obstacles to intensification of therapy
Ann Oncol 15: 363-364; doi:10.1093/annonc/mdh117
[Extract] [FREE Full Text] [PDF] [Request Permissions]

W. Eberhardt, M. Stuschke, and G. Stamatis

Preoperative chemoradiation approaches to locally advanced non-small-cell lung cancer: one man’s pride, another man’s burden?
Ann Oncol 15: 365-367; doi:10.1093/annonc/mdh118
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

E. Weidmann, M. Gramatzki, M. Wilhelm, and P. S. Mitrou

Diagnosis and actual therapy strategies in peripheral T-cell lymphomas: summary of an international meeting
Ann Oncol 15: 369-374; doi:10.1093/annonc/mdh085
[Extract] [FREE Full Text] [PDF] [Request Permissions]

K. Reynen, U. Köckeritz, and R. H. Strasser

Metastases to the heart
Ann Oncol 15: 375-381; doi:10.1093/annonc/mdh086
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Head and neck cancer:

N. P. Nguyen, C. C. Moltz, C. Frank, P. Vos, H. J. Smith, U. Karlsson, S. Dutta, F. A. Midyett, J. Barloon, and S. Sallah

Dysphagia following chemoradiation for locally advanced head and neck cancer
Ann Oncol 15: 383-388; doi:10.1093/annonc/mdh101
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

L. Trodella, P. Granone, S. Valente, S. Margaritora, G. Macis, A. Cesario, R. M. D’Angelillo, V. Valentini, G. M. Corbo, V. Porziella, S. Ramella, G. Tonini, D. Galetta, M. Ciresa, B. Vincenzi, and N. Cellini

Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA–IIIB) non-small-cell lung cancer: long-term results according to downstaging
Ann Oncol 15: 389-398; doi:10.1093/annonc/mdh099
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J.-P. Sculier, J.-J. Lafitte, T. Berghmans, P. Van Houtte, J. Lecomte, J. Thiriaux, A. Efremidis, G. Koumakis, V. Giner, M. Richez, J.-L. Corhay, P. Wackenier, P. Lothaire, M. Paesmans, P. Mommen, and V. Ninane

A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer
Ann Oncol 15: 399-409; doi:10.1093/annonc/mdh105
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. M. Rocha Lima, N. A. Rizvi, C. Zhang, J. E. Herndon, 2nd, J. Crawford, R. Govindan, G. W. King, and M. R. Green

Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC
Ann Oncol 15: 410-418; doi:10.1093/annonc/mdh104
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. Gridelli, A. Ardizzoni, T. Le Chevalier, C. Manegold, F. Perrone, N. Thatcher, N. van Zandwijk, M. Di Maio, O. Martelli, and F. De Marinis

Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
Ann Oncol 15: 419-426; doi:10.1093/annonc/mdh087
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

H. J. M. Groen, A. H. W. van der Leest, E. Fokkema, P. R. Timmer, G. D. Nossent, W. J. G. M. Smit, J. Nabers, H. J. Hoekstra, J. Hermans, R. Otter, J. W. G. van Putten, E. G. E. de Vries, and N. H. Mulder

Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study
Ann Oncol 15: 427-432; doi:10.1093/annonc/mdh100
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

S. Cresta, G. Grasselli, M. Mansutti, A. Martoni, G. Lelli, G. Capri, F. Buzzi, G. Robustelli Della Cuna, A. Jirillo, E. Terzoli, L. Frevola, E. Tarenzi, C. Sguotti, N. Azli, M. Murawsky, and L. Gianni

A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer
Ann Oncol 15: 433-439; doi:10.1093/annonc/mdh107
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. E. R. O’Brien, N. Wigler, M. Inbar, R. Rosso, E. Grischke, A. Santoro, R. Catane, D. G. Kieback, P. Tomczak, S. P. Ackland, F. Orlandi, L. Mellars, L. Alland, and C. Tendler

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX^TM/Doxil^®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
Ann Oncol 15: 440-449; doi:10.1093/annonc/mdh097
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Mendez, F. Cabanillas, M. Echenique, K. Malekshamran, I. Perez, and E. Ramos

Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB)
Ann Oncol 15: 450-454; doi:10.1093/annonc/mdh088
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. M. Ali, L. M. Demers, K. Leitzel, H. A. Harvey, D. Clemens, N. Mallinak, L. Engle, V. Chinchilli, L. Costa, C. Brady, J. Seaman, and A. Lipton

Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis
Ann Oncol 15: 455-459; doi:10.1093/annonc/mdh089
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

L. Rubbia-Brandt, V. Audard, P. Sartoretti, A. D. Roth, C. Brezault, M. Le Charpentier, B. Dousset, P. Morel, O. Soubrane, S. Chaussade, G. Mentha, and B. Terris

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
Ann Oncol 15: 460-466; doi:10.1093/annonc/mdh095
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Ducreux, E. Mitry, M. Ould-Kaci, V. Boige, J. F. Seitz, R. Bugat, J. L. Breau, O. Bouché, P. L. Etienne, J. M. Tigaud, F. Morvan, E. Cvitkovic, and P. Rougier

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
Ann Oncol 15: 467-473; doi:10.1093/annonc/mdh098
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Novarino, I. Chiappino, G. F. Bertelli, A. Heouaine, G. Ritorto, A. Addeo, G. Bellone, M. Merlano, and O. Bertetto

Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer
Ann Oncol 15: 474-477; doi:10.1093/annonc/mdh106
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. V. Kornek, B. Schuell, F. Laengle, T. Gruenberger, M. Penz, K. Karall, D. Depisch, F. Lang, and W. Scheithauer

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial
Ann Oncol 15: 478-483; doi:10.1093/annonc/mdh096
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. M. De Lange, C. J. van Groeningen, J. R. Kroep, A. Van Bochove, J. F. Snijders, G. J. Peters, H. M. Pinedo, and G. Giaccone

Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer
Ann Oncol 15: 484-488; doi:10.1093/annonc/mdh109
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Graziano, F. Arduini, A. Ruzzo, A. Mandolesi, I. Bearzi, R. Silva, P. Muretto, E. Testa, D. Mari, M. Magnani, M. Scartozzi, and S. Cascinu

Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs
Ann Oncol 15: 489-492; doi:10.1093/annonc/mdh108
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Urogenital tumors:

D. Pectasides, M. Pectasides, D. Farmakis, G. Aravantinos, M. Nikolaou, M. Koumpou, A. Gaglia, V. Kostopoulou, N. Mylonakis, and D. Skarlos

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study
Ann Oncol 15: 493-497; doi:10.1093/annonc/mdh103
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Miscellaneous tumors:

G. Gamberi, M. S. Benassi, P. Ragazzini, L. Pazzaglia, F. Ponticelli, C. Ferrari, A. Balladelli, M. Mercuri, M. Gigli, F. Bertoni, and P. Picci

Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone
Ann Oncol 15: 498-503; doi:10.1093/annonc/mdh091
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

K. Belhadj, M.-H. Delfau-Larue, T. Elgnaoui, F. Beaujean, J.-L. Beaumont, C. Pautas, I. Gaillard, Y. Kirova, A. Allain, P. Gaulard, J.-P. Farcet, F. Reyes, and C. Haioun

Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin’s lymphoma: a single institution study
Ann Oncol 15: 504-510; doi:10.1093/annonc/mdh090
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Jermann, L. M. Jost, Ch. Taverna, E. Jacky, H. P. Honegger, D. C. Betticher, F. Egli, Th. Kroner, and R. A. Stahel

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study
Ann Oncol 15: 511-516; doi:10.1093/annonc/mdh093
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

Y. Matsumura, M. Gotoh, K. Muro, Y. Yamada, K. Shirao, Y. Shimada, M. Okuwa, S. Matsumoto, Y. Miyata, H. Ohkura, K. Chin, S. Baba, T. Yamao, A. Kannami, Y. Takamatsu, K. Ito, and K. Takahashi

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Ann Oncol 15: 517-525; doi:10.1093/annonc/mdh092
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Supportive care:

A. Ihbe-Heffinger, B. Ehlken, R. Bernard, K. Berger, C. Peschel, H.-G. Eichler, R. Deuson, J. Thödtmann, and F. Lordick

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers
Ann Oncol 15: 526-536; doi:10.1093/annonc/mdh110
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

N. Fuente, J. M. Mañe, R. Barcelo, A. Muñoz, T. Perez-Hoyos, and G. Lopez-Vivanco

Tumor lysis syndrome in a multiple myeloma treated with thalidomide
Ann Oncol 15: 537; doi:10.1093/annonc/mdh116
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. M. Westermann

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
Ann Oncol 15: 537-538; doi:10.1093/annonc/mdh111
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Amsellem-Ouazana, P. Beuzeboc, M. Peyromaure, A. Viellefond, M. Zerbib, and B. Debre

Management of primary resistance to gemcitabine and cisplatin (G–C) chemotherapy in metastatic bladder cancer with HER2 over-expression
Ann Oncol 15: 538; doi:10.1093/annonc/mdh112
[Extract] [FREE Full Text] [PDF] [Request Permissions]

G. Todeschini, S. Gelio, and C. Tecchio

Rituximab–CHOP or two-weekly CHOP + G-CSF in aggressive lymphoma of the elderly?
Ann Oncol 15: 538-539; doi:10.1093/annonc/mdh113
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. L. Basquiera, A. R. Berretta, J. J. García, and E. D. Palazzo

Coronary ischemia related to alemtuzumab therapy
Ann Oncol 15: 539-540; doi:10.1093/annonc/mdh114
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Corrigenda:

J. Vose and V. Sneller

Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin’s lymphoma
Ann Oncol 15: 541; doi:10.1093/annonc/mdh129
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.